Skip to main content
. 2024 Jun 20;2:43. doi: 10.1038/s44276-024-00067-5

Fig. 3.

Fig. 3

Progression-free (top) and overall (bottom) survival among patients in the setting of ixabepilone dose reductions (left, none; middle, one dose reduction, right, two dose reductions).